RemeGen Co., Ltd. disclosed its monthly return for January 2026, detailing the status of its H shares and A shares. According to the announcement, the total authorized share capital at the end of the month reached RMB 564,477,483, comprising H shares listed in Hong Kong and A shares listed on the Shanghai Stock Exchange.

The Hong Kong-listed H shares (stock code 09995) remained unchanged, with an issued share count of 208,581,239. This class of shares continues to meet the public float requirement set at 24.16%. Meanwhile, the A shares (stock code 688331) saw their authorized share capital rise from RMB 355,129,004 to RMB 355,896,244, driven in part by share issuances under RemeGen’s share incentive schemes.

In total, 573,096 new A shares were issued, partially offset by the repurchase of 194,144 A shares that were held in treasury for potential application under employee incentive plans. The final issued total for A shares stood at 355,702,100, with 194,144 shares in treasury, bringing the aggregate to 355,896,244.

Additional details indicate that the share incentive schemes involved restricted shares granted at predetermined prices, and a portion of those shares lapsed or were attributed. These transactions reflect RemeGen’s ongoing efforts to align employee interests with the company’s long-term development.